These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9933342)

  • 41. Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole.
    Fukuchi K; Kusuoka H; Watanabe Y; Fujiwara T; Nishimura T
    J Nucl Med; 1996 May; 37(5):761-6. PubMed ID: 8965142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preclinical assessment of hypoxic marker specificity and sensitivity.
    Iyer RV; Engelhardt EL; Stobbe CC; Schneider RF; Chapman JD
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):741-5. PubMed ID: 9845088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship between magnetic resonance diffusion imaging and autoradiographic markers of cerebral blood flow and hypoxia in an animal stroke model.
    Lythgoe MF; Williams SR; Busza AL; Wiebe L; McEwan AJ; Gadian DG; Gordon I
    Magn Reson Med; 1999 Apr; 41(4):706-14. PubMed ID: 10332845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of [18F]-4-fluoroantipyrine as a new blood flow tracer for multiradionuclide autoradiography.
    Sako K; Diksic M; Kato A; Yamamoto YL; Feindel W
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):259-63. PubMed ID: 6609931
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
    Hoffend J; Linke G; Mohammed A; Tiefenbacher CP; Eisenhut M; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.
    Lehtiö K; Oikonen V; Nyman S; Grönroos T; Roivainen A; Eskola O; Minn H
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):101-8. PubMed ID: 12483416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of hypoxia to the development of cardiomyopathy in hamsters.
    Watanabe Y; Kusuoka H; Fukuchi K; Fujiwara T; Nishimura T
    Cardiovasc Res; 1997 Aug; 35(2):217-22. PubMed ID: 9349384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Initial cerebral HM-PAO distribution compared to LCBF: use of a model which considers cerebral HM-PAO trapping kinetics.
    Lear JL
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S31-7. PubMed ID: 3263979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-induced redox alterations and their correlation with 99mTc-MIBI and 99mTc-HL-91 uptake in colon cancer cells.
    Abrantes AM; Serra ME; Gonçalves AC; Rio J; Oliveiros B; Laranjo M; Rocha-Gonsalves AM; Sarmento-Ribeiro AB; Botelho MF
    Nucl Med Biol; 2010 Feb; 37(2):125-32. PubMed ID: 20152711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein kinase C in focal ischemic rat brain: dual autoradiographic analysis of [14C]iodoantipyrine (IAP) and [3H]phorbol-12,13-dibutyrate (PDBu).
    Tohyama Y; Sako K; Yonemasu Y
    Brain Res; 1997 Mar; 750(1-2):155-60. PubMed ID: 9098540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of regional distribution of renal blood flow using quantitative autoradiography.
    Geraghty JG; Nsubuga M; Angerson WJ; Williams NN; Sarazen AA; Dervan PA; Fitzpatrick JM
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F958-62. PubMed ID: 1443184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.
    Walovitch RC; Hill TC; Garrity ST; Cheesman EH; Burgess BA; O'Leary DH; Watson AD; Ganey MV; Morgan RA; Williams SJ
    J Nucl Med; 1989 Nov; 30(11):1892-901. PubMed ID: 2809756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow.
    Beanlands R; Muzik O; Nguyen N; Petry N; Schwaiger M
    J Am Coll Cardiol; 1992 Sep; 20(3):712-9. PubMed ID: 1512353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increases in brain tumor and cerebral blood flow by blood-perfluorochemical emulsion (Fluosol-DA) exchange.
    Hiraga S; Klubes P; Owens ES; Cysyk RL; Blasberg RG
    Cancer Res; 1987 Jun; 47(12):3296-302. PubMed ID: 3581070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
    Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
    J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
    Grönroos T; Bentzen L; Marjamäki P; Murata R; Horsman MR; Keiding S; Eskola O; Haaparanta M; Minn H; Solin O
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):513-20. PubMed ID: 14722675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional coupling of blood flow and methionine uptake in an experimental tumor assessed with autoradiography.
    Abe Y; Matsuzawa T; Itoh M; Ishiwata K; Fujiwara T; Sato T; Yamaguchi K; Ido T
    Eur J Nucl Med; 1988; 14(7-8):388-92. PubMed ID: 3181188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood flow, volume and arterio-venous passages in induced mammary tumours of the rat.
    Hultborn R
    Microvasc Res; 2018 Mar; 116():45-49. PubMed ID: 29069572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.